Lánczky A - Search Results

1

Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer.

Magnani L, Stoeck A, Zhang X, Lánczky A, Mirabella AC, Wang TL, Gyorffy B, Lupien M. Magnani L, et al. Among authors: lanczky a. Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):E1490-9. doi: 10.1073/pnas.1219992110. Epub 2013 Apr 1. Proc Natl Acad Sci U S A. 2013. PMID: 23576735 Free PMC article.

2

Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.

Gyorffy B, Lánczky A, Szállási Z. Gyorffy B, et al. Among authors: lanczky a. Endocr Relat Cancer. 2012 Apr 10;19(2):197-208. doi: 10.1530/ERC-11-0329. Print 2012 Apr. Endocr Relat Cancer. 2012. PMID: 22277193 Free article.

3

Survival analysis in breast cancer using proteomic data from four independent datasets.

Ősz Á, Lánczky A, Győrffy B. Ősz Á, et al. Among authors: lanczky a. Sci Rep. 2021 Aug 18;11(1):16787. doi: 10.1038/s41598-021-96340-5. Sci Rep. 2021. PMID: 34408238 Free PMC article.

4

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.

Györffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. Györffy B, et al. Among authors: lanczky a. Breast Cancer Res Treat. 2010 Oct;123(3):725-31. doi: 10.1007/s10549-009-0674-9. Epub 2009 Dec 18. Breast Cancer Res Treat. 2010. PMID: 20020197

5

RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data.

Győrffy B, Benke Z, Lánczky A, Balázs B, Szállási Z, Timár J, Schäfer R. Győrffy B, et al. Among authors: lanczky a. Breast Cancer Res Treat. 2012 Apr;132(3):1025-34. doi: 10.1007/s10549-011-1676-y. Epub 2011 Jul 16. Breast Cancer Res Treat. 2012. PMID: 21773767

6

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.

Lánczky A, Győrffy B. Lánczky A, et al. J Med Internet Res. 2021 Jul 26;23(7):e27633. doi: 10.2196/27633. J Med Internet Res. 2021. PMID: 34309564 Free PMC article.

7

A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.

Mihály Z, Kormos M, Lánczky A, Dank M, Budczies J, Szász MA, Győrffy B. Mihály Z, et al. Among authors: lanczky a. Breast Cancer Res Treat. 2013 Jul;140(2):219-32. doi: 10.1007/s10549-013-2622-y. Epub 2013 Jul 9. Breast Cancer Res Treat. 2013. PMID: 23836010

8

Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.

Győrffy B, Surowiak P, Budczies J, Lánczky A. Győrffy B, et al. Among authors: lanczky a. PLoS One. 2013 Dec 18;8(12):e82241. doi: 10.1371/journal.pone.0082241. eCollection 2013. PLoS One. 2013. PMID: 24367507 Free PMC article.

9

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer.

Pénzváltó Z, Lánczky A, Lénárt J, Meggyesházi N, Krenács T, Szoboszlai N, Denkert C, Pete I, Győrffy B. Pénzváltó Z, et al. Among authors: lanczky a. BMC Cancer. 2014 Nov 18;14:837. doi: 10.1186/1471-2407-14-837. BMC Cancer. 2014. PMID: 25408231 Free PMC article.

10

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.

Lánczky A, Nagy Á, Bottai G, Munkácsy G, Szabó A, Santarpia L, Győrffy B. Lánczky A, et al. Breast Cancer Res Treat. 2016 Dec;160(3):439-446. doi: 10.1007/s10549-016-4013-7. Epub 2016 Oct 15. Breast Cancer Res Treat. 2016. PMID: 27744485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters